T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy
Clinical trial NCT02250209 · UNKNOWN
Trial details
- NCT number
- NCT02250209
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2017-06-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.